인용/피인용
소아골수단핵구백혈병의 분자생물학적 이해
전인상
2018년
' 소아골수단핵구백혈병의 분자생물학적 이해' 의 참고문헌
-
The Cbl interactome and its functionsSchmidt MH [2005]
-
Targeting the PI3K/Akt pathway in murine MDS/MPN driven by hyperactive RasAkutagawa J [2016]
-
Subclonal mutations in SETBP1 confer a poor prognosis in juvenile myelomonocytic leukemiaStieglitz E [2015]
-
Spontaneous improvement of hematologic abnormalities in patients having juvenile myelomonocytic leukemia with specific RAS mutationsMatsuda K [2007]
-
Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemiaTartaglia M [2003]
-
Somatic mosaicism for oncogenic NRAS mutations in juvenile myelomonocytic leukemiaDoisaki S [2012]
-
Shp2, an SH2-containing protein-tyrosine phosphatase, positively regulates receptor tyrosine kinase signaling by dephosphorylating and inactivating the inhibitor SproutyHanafusa H [2004]
-
SHP2 sails from physiology to pathologyTajan M [2015]
-
RASA4 undergoes DNA hypermethylation in resistant juvenile myelomonocytic leukemiaPoetsch AR [2014]
-
RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemiaLipka DB [2017]
-
RAS mutations and clonality analysis in children with juvenile myelomonocytic leukemia (JMML)Flotho C [1999]
-
Quantitative assessment of PTPN11 or RAS mutations at the neonatal period and during the clinical course in patients with juvenile myelomonocytic leukaemiaMatsuda K [2010]
-
Protein tyrosine phosphatase SHP-2: a proto-oncogene product that promotes Ras activationMatozaki T [2009]
-
Phase II/III trial of a pre-transplant farnesyl transferase inhibitor in juvenile myelomonocytic leukemia: a report from the Children's Oncology GroupStieglitz E [2015]
-
Paediatric myelodysplastic syndromes and juvenile myelomonocytic leukaemia in the UK: a populationbased study of incidence and survivalPassmore SJ [2003]
-
Mutations in CBL occur frequently in juvenile myelomonocytic leukemiaLoh ML [2009]
-
Molecular basis of juvenile myelomonocytic leukemiade Vries AC [2010]
-
Long-term survival after nonintensive chemotherapy in some juvenile myelomonocytic leukemia patients with CBL mutations, and the possible presence of healthy persons with the mutationsMatsuda K [2010]
-
Intriguing response to azacitidine in a patient with juvenile myelomonocytic leukemia and monosomy 7Furlan I [2009]
-
How I treat juvenile myelomonocytic leukemiaLocatelli F [2015]
-
Homozygous inactivation of the NF1 gene in bone marrow cells from children with neurofibromatosis type 1 and malignant myeloid disordersSide L [1997]
-
Genotype-phenotype correlation in cases of juvenile myelomonocytic leukemia with clonal RAS mutationsFlotho C [2008]
-
Genetic disruption of the PI3K regulatory subunits, <TEX>$p85{\alpha}$</TEX>, <TEX>$p55{\alpha}$</TEX>, and <TEX>$p50{\alpha}$</TEX>, normalizes mutant PTPN11-induced hypersensitivity to GM-CSFGoodwin CB [2012]
-
Exome sequencing identifies secondary mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemiaSakaguchi H [2013]
-
Diagnosis and treatment of juvenile myelomonocytic leukemiaSakashita K [2016]
-
Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS)Niemeyer CM [1997]
-
Chromosomal change during 6-mercaptopurine (6-MP) therapy in juvenile myelomonocytic leukemia: the growth of a 6-MP-refractory clone that already exists at onsetMatsuda K [2006]
-
Bridging to transplant with azacitidine in juvenile myelomonocytic leukemia: a retrospective analysis of the EWOG-MDS study groupCseh A [2015]
-
Bedside to bench in juvenile myelomonocytic leukemia: insights into leukemogenesis from a rare pediatric leukemiaChang TY [2014]
-
Aberrant DNA methylation characterizes juvenile myelomonocytic leukemia with poor outcomeOlk-Batz C [2011]